Brain cholesterol homeostasis in Wilson disease

Medical Hypotheses

Volumn 81, Issue 6, 2013, Pages 1127-1129

  Cacciatore, Stefano ^a,b   Tenori, Leonardo ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c FiorGen Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ACETYL COENZYME A; CHOLESTEROL; COPPER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; TRANSCRIPTION FACTOR;

ARTICLE; BRAIN MATURATION; CATABOLISM; CHOLESTEROL SYNTHESIS; HOMEOSTASIS; HUMAN; HYPOTHESIS; LIPID RAFT; MOLECULAR INTERACTION; NEUROLOGIC DISEASE; NONHUMAN; WILSON DISEASE;

BRAIN; CHOLESTEROL; COPPER; HEPATOLENTICULAR DEGENERATION; HOMEOSTASIS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL;

EID: 84888436499     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.10.018     Document Type: Article

References (35)

1. Maxfield F.R., Tabas I. Role of cholesterol and lipid organization in disease. Nature 2005, 438(7068):612-621.
2. Allen J.A., Halverson-Tamboli R.A., Rasenick M.M. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 2007, 8(2):128-140.
3. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001, 294(5545):1354-1357.
4. Dietschy J.M., Turley S.D. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 2004, 45(8):1375-1397.
5. Haines T.H. Do sterols reduce proton and sodium leaks through lipid bilayers?. Prog Lipid Res 2001, 40:299-324.
6. Pfrieger F.W. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci: CMLS 2003, 60(6):1158-1171.
7. Ullian E.M., Sapperstein S.K., Christopherson K.S., Barres B.A. Control of synapse number by glia. Science 2001, 291(5504):657-661.
8. Pfrieger F.W., Barres B.A. Synaptic efficacy enhanced by glial cells in vitro. Science 1997, 277(5332):1684-1687.
9. Bjorkhem I., Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 2004, 24(5):806-815.
10. Bjorkhem I., Lutjohann D., Diczfalusy U., Stahle L., Ahlborg G., Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 1998, 39(8):1594-1600.
11. Bekersky I., Fielding R.M., Dressler D.E., Kline S., Buell D.N., Walsh T.J. Pharmacokinetics, excretion, and mass balance of 14C after administration of 14C-cholesterol-labeled Am Bisome to healthy volunteers. J Clin Pharmacol 2001, 41(9):963-971.
12. Björkhem I., Leoni V., Meaney S. Genetic connections between neurological disorders and cholesterol metabolism. J Lipid Res 2010, 51:2489-2503.
13. Lutjohann D., Breuer O., Ahlborg G., et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA 1996, 93(18):9799-9804.
14. Bjorkhem I., Lutjohann D., Breuer O., Sakinis A., Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J Biol Chem 1997, 272(48):30178-30184.
15. Ohyama Y., Meaney S., Heverin M., et al. Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes. J Biol Chem 2006, 281(7):3810-3820.
16. Lund E.G., Xie C., Kotti T., Turley S.D., Dietschy J.M., Russell D.W. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem 2003, 278(25):22980-22988.
17. Kotti T.J., Ramirez D.M., Pfeiffer B.E., Huber K.M., Russell D.W. Brain cholesterol turnover required for geranylgeraniol production and learning in mice. Proc Natl Acad Sci USA 2006, 103(10):3869-3874.
18. Smiljanic K., Lavrnja I., Mladenovic Djordjevic A., et al. Brain injury induces cholesterol 24-hydroxylase (Cyp46) expression in glial cells in a time-dependent manner. Histochem Cell Biol 2010, 134(2):159-169.
19. Appelqvist H., Sandin L., Bjornstrom K., et al. Sensitivity to lysosome-dependent cell death is directly regulated by lysosomal cholesterol content. PloS One 2012, 7(11):e50262.
20. Smith M.A., Richey P.L., Taneda S., et al. Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann N Y Acad Sci 1994, 738:447-454.
21. Huang X., Cuajungco M.P., Atwood C.S., et al. Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 1999, 274(52):37111-37116.
22. Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 2002, 32(11):1050-1060.
23. Ala A., Walker A.P., Ashkan K., Dooley J.S., Schilsky M.L. Wilson's disease. Lancet 2007, 369(9559):397-408.
24. Frydman M., Bonne-Tamir B., Farrer L.A., et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci USA 1985, 82(6):1819-1821.
25. Bull P.C., Thomas G.R., Rommens J.M., Forbes J.R., Cox D.W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Genet 1993, 5(4):327-337.
26. Wu J., Forbes J.R., Chen H.S., Cox D.W. The LEC rat has a delection in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet 1994, 7:541-545.
27. Theophilos M.B., Cox D.W., Mercer J.F. The toxic milk mouse is a murine model of Wilson disease. Hum Mol Genet 1996, 5:1619-1624.
28. Buiakova O.I., Xu J., Lutsenko S., et al. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum Mol Genet 1999, 8:1665-1671.
29. -/- (Wilson disease gene) knockout mice. Am J Pathol 2006, 168:423-434.
30. Merle U., Tuma S., Herrmann T., et al. Evidence for a critical role of ceruloplasmin oxidase activity in iron metabolism of Wilson disease gene knockout mice. J Gastroenterol Hepatol 2010, 25:1144-1150.
31. Huster D., Prnat T.D., Burkhead J.L., et al. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J Biol Chem 2007, 282:8343-8355.
32. -/- mice as a model for Wilson disease. Biochim Biophys Acta 2011, 1812(12):1607-1615.
33. Bush A.I., Tanzi R.E. Therapeutics for Alzheimer's disease based on the metal hypothesis. Neurotherapeutics 2008, 5(3):421-432.
34. Rose F., Hodak M., Bernholc J. Mechanism of copper(II)-induced misfolding of Parkinson's disease protein. Sci Rep 2011, 1:11.
35. Leoni V., Caccia C. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases. Biochimie 2013, 95(3):595-612.